Statera Biopharma, Inc.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 16
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 2
2 (100.0%)Treatment of Advanced Renal Cell Carcinoma With Quinacrine
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2015-08-03
- Lead Sponsor
- Cleveland BioLabs
- Registration Number
- NCT00574483
- Locations
- πΊπΈ
Community Care Physicians, Albany, New York, United States
πΊπΈClinWorks Cancer Research Center, Charlotte, North Carolina, United States
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
- First Posted Date
- 2006-12-29
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Cleveland BioLabs
- Target Recruit Count
- 31
- Registration Number
- NCT00417274
News
No news found